INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Page 156 of 1649
← PrevNext →
Oct 16, 2026
Oct 19, 2026
traded Oct 16, 2026
+3d
SEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.14M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
410.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
KM
Kiernan MichaelChief Revenue Officer
NXDRNextdoor Holdings, Inc.
Option exercise
M—
27.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$255K
1,129 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.14M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
731.2K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.15M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
306.7K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
WY
Woo Ian YingDirector
NBPNovaBridge Biosciences
Option exercise
M—
13.3K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
RB
Raiford BrittanyVP, Treasurer
EXEEXPAND ENERGY Corp
Tax withholding
F$46K
511 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
MJ
Mueller David JDirector
SMASmartStop Self Storage REIT, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
425 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
CE
Carlsen ElyseCAO
RSGREPUBLIC SERVICES, INC.
Grant or award
A$919
4 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
CE
Carlsen ElyseCAO
RSGREPUBLIC SERVICES, INC.
Grant or award
A$161
1 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SE
Schreiner Megan E.PRESIDENT
NONENONESterling Real Estate Trust
Grant or award
A$1,824
75 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SE
Schreiner Megan E.PRESIDENT
NONENONESterling Real Estate Trust
Grant or award
A$84.69
3 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SE
Schreiner Megan E.PRESIDENT
NONENONESterling Real Estate Trust
Grant or award
A$84.69
3 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
BF
Baumgartner FlorianEVP and CEO, Vista
CMPRCIMPRESS plc
Option exercise
M—
1,025 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
BF
Baumgartner FlorianEVP and CEO, Vista
CMPRCIMPRESS plc
Tax withholding
F$36K
487 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
CP
Carlson Michael PaulGENERAL COUNSEL & SECRETARY
NONENONESterling Real Estate Trust
Grant or award
A$172
7 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
122.7K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$798K
3,520 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$338K
1,487 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
SM
Secora MichaelCFO & Chief Corp Dev Ofcr
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
61.3K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
LC
Lisowski CraigPresident of Products
NXDRNextdoor Holdings, Inc.
Option exercise
M—
41.4K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
TN
Tolia Nirav NDirector, CEO and President, 10% Owner
NXDRNextdoor Holdings, Inc.
Option exercise
M—
45.1K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
TN
Tolia Nirav NDirector, CEO and President, 10% Owner
NXDRNextdoor Holdings, Inc.
Tax withholding
F$46K
17.8K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
TN
Tolia Nirav NDirector, CEO and President, 10% Owner
NXDRNextdoor Holdings, Inc.
Option exercise
M—
110.5K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
BV
Burnett VeraCFO and Treasurer
EBFENNIS, INC.
Option exercise
M$35K
2,000 sh
Oct 19, 2026Oct 19, 2026
traded Oct 19, 2026
+0dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$824K
3,406 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$593K
2,439 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$332K
1,360 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$305K
1,246 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$294K
1,299 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$378K
1,608 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1.79M
200.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K